A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Histocompatibility Laboratory Bookmark and Share

Histocompatibility Laboratory

The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 1 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Histocompatibility Laboratory

Histocompatibility Laboratory

The Histocompatibility Laboratory at City of Hope provides the highest standard of human leukocyte antigen typing services on a contract basis, as well as for City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. In operation since 1975, our clientele includes a number of prominent institutions such as Kaiser Permanente of Southern California, Loyola University in Chicago, BloodSource and the University of California at Davis, among others. The Histocompatibility Laboratory is staffed by specially trained technologists and utilizes state-of-the-art technology in the field of histocompatibility.
 
High Quality Service and Rapid Response
City of Hope’s Histocompatibility Laboratory maintains high quality service and rapid response times. With the exception of unique circumstances, we communicate HLA typing results within a maximum of ten (10) working days upon receipt of a blood specimen. Results of histocompatibility testing can be reported by phone, fax or email as soon as they are available, and will be followed by an official written report.
 
Licenses and Accreditations
City of Hope’s Histocompatibility Laboratory is fully accredited by The American Society of Histocompatibility and Immunogenetics (ASHI), College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA 88).
 
The laboratory holds the following licenses:
  • CLIA #05D0665695
  • CA State License #209978

HLA and Stem Cell Transplantation

HLA and Stem Cell Transplantation

This page explains the field of “HLA,” its role in stem cell transplantation and some relevant terminology. It also addresses the blood tests your doctor will order before a stem cell transplant, and the useful information the blood sample provides.
 
Stem Cell Transplants
In order to treat certain diseases, it is necessary to give whole body irradiation and high dose chemotherapy. While this therapy destroys malignant cells, unfortunately it also destroys the cells responsible for generating red blood cells, white blood cells and platelets. In order for the patient to survive after radiation and chemotherapy, these cells (called “hematopoietic stem cells”) must be transfused back into the patient. They then migrate to the bone marrow, divide, and eventually produce new blood cells and platelets.

There are three main sources of hematopoietic stem cells. Stem cells that circulate throughout the blood stream are called “peripheral blood stem cells” or PBSCs. Another source is the bone marrow, where most stem cells reside. A third source of stem cells is the umbilical cord of a newborn baby.

If the hematopoietic stem cells transfused into the patient are from another individual, it is best if the cells carry the same HLA molecules as the patient – otherwise, the patient may either reject the stem cell transplant or the transplanted stem cells may react to the patient’s tissues in what is termed “graft versus host disease.”
 
What is HLA?
HLA stands for “Human Leukocyte Antigen.” These are protein molecules that we inherit from our parents. We currently know about nearly 600 different HLA molecules. Before you have a stem cell transplant, your HLA type must be determined. This is done by taking a blood sample.

The laboratory will also determine the HLA type of anyone who may donate stem cells to you. It is important in stem cell transplants to see how closely the HLA of the transplant patient matches the HLA of the stem cell donor. The HLA “match” is the number of HLA molecules that any two people have in common. HLA matching is usually based on six HLA molecules. The more molecules two people share, the better the match. When two individuals share the same HLA type, they are said to be a good match. That is, their immune systems will not see each other as “foreign” and are less likely to attack each other.

The most likely place to find an HLA match between two people is among siblings (brothers and sisters who have the same mother and same father). If two siblings inherit the very same HLA molecules from both parents, they are said to be an “HLA identical match.”

You have a 25 percent (1 in 4) chance of being an HLA identical match with your sibling. Why? Because there is a basic rule in HLA inheritance: you have a 25 percent chance of inheriting the same HLA molecules as your sibling, a 25 percent chance of inheriting none of the same HLA molecules as your sibling, and a 50 percent chance of inheriting half of the same HLA molecules as your sibling.

However, two unrelated people can just happen to be a good HLA match, too. Although it is less likely, it is possible that you could have some of the same HLA molecules as a friend or as someone you don’t even know. If you and your friend share three HLA molecules, for example, then you are said to be a “three HLA antigen match.”

Finding the Best Match
When a doctor decides that a stem cell transplant is the best treatment for a patient, he or she will request a family study. The patient, all of his or her siblings, and usually their parents will have their blood drawn for HLA typing. If one of the family members is an HLA identical match, the lab will do further testing to be absolutely sure that they are the best match possible. This usually involves taking the patient’s and the donor’s DNA from the blood cells and typing the HLA genes to show that they are identical.

If none of the siblings or the parents are a good HLA match, the doctor will sometimes ask to have additional family members tested. These are usually aunts, uncles, cousins and grandparents. If it happens that there are no close HLA matches within the patient’s family,a search will be initiated for an unrelated donor with the same HLA molecules as the patient.
 
Glossary of HLA Terms
  • HLA: human leukocyte antigen, proteins we inherit from our parents
  • HLA Matching: the number of HLA molecules two people have in common
  • HLA Antibodies: proteins in the patient's blood against the donor's HLA that could attack transplanted or transfused cells
  • PRA: panel reactive antibody, a measure of how much HLA antibody the patient has
  • Stem Cell: cells responsible for generating red blood cells, white blood cells, and platelets
  • Red Blood Cell: the cells that carry oxygen to all parts of the body
  • White Blood Cell: the cells of the immune system that fight off germs
  • Platelets: the cells that form clots to stop bleeding
  • Bone Marrow: the inner spongy portion of large bones, where most stem cells reside
  • Graft versus Host Disease: an immune attack by transplanted donor cells against the patient’s body
  • ABO: blood type, a person can be A, B, AB or O blood type

Available Tests

Available Tests

In addition to standard typing as itemized in the chart below, City of Hope's Histocompatiblity Laboratory now offers:

Tests                                                          Methodology
 
HLA-AB Typing                                                               Luminex
 
Donor/Recipient Crossmatch                                    Serology
 
HLA Antibody Screening                                              Serology/SSOP
 
B27 Typing                                                                      PCR-SSP/SBT
 
HLA-ABC Low Resolution Typing                               SSOP
 
HLA-DRB1, DQB1 Low Resolution Typing               SSOP
 
HLA-ABC High Resolution Typing                              PCR-SSP or SBT
 
HLA-DRB1, DPB1, DQB1 High ResolutionTyping  PCR-SSP or SBT

Engraftment Analysis                                                   Short Tandem Repeat
 
 
 
Fees for tests will be provided upon request.
 

Specimen Requirements

Specimen Requirements

Please adhere to these instructions for sampling and labeling.
 
Requisition Form
  • Download the requisition form here in Adobe Acrobat (.pdf) format. If you don't have Adobe Acrobat Reader, you can download it for free here.
  • Specimens should be sent with a completed requisition form for overnight delivery using proper handling techniques.
  • Include completed HLA Laboratory requisition form with shipment.
  • Call the laboratory at (877) 443-GENE (4363) upon shipping the specimens.
 
Before the Specimen is Drawn
  • Call the laboratory at (877) 443-GENE (4363) to schedule testing.
 
Drawing and Storing Specimen for Shipment
  • 5-10 cc of blood should be drawn and immediately transferred into 1 yellow tope tubes (ACD Solution A) and one red top tube.
  • Mix well by inverting tubes several times.
  • Store specimen at room temperature.
  • Include completed HLA Laboratory requisition form with shipment.
     
Labeling Specimen
  • Please label each sample with the following information:
  • Date blood was drawn
  • Name, birthday, race and patient’s I.D. number
  • Recipient/donor relationship
 
 

Contact Us

Contact Us

For more information or to request a test, please contact us via:

Phone: 877-443-GENE (4363)
Fax: 626-301-8888
Email: dsenitzer@coh.org

City of Hope
Attention: Histocompatibility Laboratory
1500 E. Duarte Road
Duarte, CA 91010

Directions and Maps

Patient Care Overview

City of Hope Locations

Cancer Care
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.
 

For the 11th year, U.S.News & World Report has named City of Hope one of the top cancer hospitals in the country.
NEWS & UPDATES
  • Although chemotherapy can be effective in treating cancer, it can also exact a heavy toll on a patient’s health. One impressive alternative researchers have found is in the form of a vaccine. A type of immunotherapy, one part of the vaccine primes the body to react strongly against a tumor; the second part dire...
  • The breast cancer statistic is attention-getting: One in eight women will be diagnosed with breast cancer during her lifetime. That doesn’t mean that, if you’re one of eight women at a dinner table, one of you is fated to have breast cancer (read more on that breast cancer statistic), but it does mean that the ...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...